Birdwatch Note
2024-03-04 20:45:33 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
De nombreux essais clinique randomisés ont démontré que l’hydroxychloroquine (protocole de soins de @IHU_Marseille) était inefficace dans le traitement du Covid-19 , voire délétère en provoquant une surmortalité. https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19 https://www.nejm.org/doi/10.1056/NEJMoa2022926 https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013587.pub2&doi=10.1002%2F14651858.CD013587.pub2&type=cdsr&contentLanguage=
Written by 26C116DA758FCE316BB25B711BEB363E165A7F65E91BC88C17FA961515FE1D30
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1764716636185956454
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1764754072823853072
- noteId - 1764754072823853072
- participantId -
- noteAuthorParticipantId - 26C116DA758FCE316BB25B711BEB363E165A7F65E91BC88C17FA961515FE1D30 Participant Details
- createdAtMillis - 1709585133165
- tweetId - 1764716636185956454
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- De nombreux essais clinique randomisés ont démontré que l’hydroxychloroquine (protocole de soins de @IHU_Marseille) était inefficace dans le traitement du Covid-19 , voire délétère en provoquant une surmortalité. https://ansm.sante.fr/actualites/lansm-rappelle-que-lhydroxychloroquine-lazithromycine-et-livermectine-ne-constituent-pas-des-traitements-du-covid-19 https://www.nejm.org/doi/10.1056/NEJMoa2022926 https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013587.pub2&doi=10.1002%2F14651858.CD013587.pub2&type=cdsr&contentLanguage=
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-03-04 20:45:33 UTC (1709585133165) |
2024-03-05 00:15:45 UTC (1709597745232) |
CURRENTLY_RATED_HELPFUL | 2024-03-07 12:28:42 UTC (1709814522945) |
NEEDS_MORE_RATINGS | 2024-03-05 00:15:45 UTC (1709597745232) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-03-06 02:18:48 -0600 | Rating Details | |
| 2024-03-06 01:24:36 -0600 | Rating Details | |
| 2024-03-05 22:07:00 -0600 | Rating Details | |
| 2024-03-05 10:35:10 -0600 | Rating Details | |
| 2024-03-05 09:45:04 -0600 | Rating Details | |
| 2024-03-05 06:38:59 -0600 | Rating Details | |
| 2024-03-05 06:04:16 -0600 | Rating Details | |
| 2024-03-05 05:10:11 -0600 | Rating Details | |
| 2024-03-05 04:32:10 -0600 | Rating Details | |
| 2024-03-05 03:01:55 -0600 | Rating Details | |
| 2024-03-05 01:22:07 -0600 | Rating Details | |
| 2024-03-05 01:20:37 -0600 | Rating Details | |
| 2024-03-05 01:10:00 -0600 | Rating Details | |
| 2024-03-05 00:37:34 -0600 | Rating Details | |
| 2024-03-04 23:33:31 -0600 | Rating Details | |
| 2024-03-04 17:56:11 -0600 | Rating Details | |
| 2024-03-04 17:44:36 -0600 | Rating Details | |
| 2024-03-04 16:52:12 -0600 | Rating Details | |
| 2024-03-04 16:50:04 -0600 | Rating Details | |
| 2024-03-04 15:14:23 -0600 | Rating Details | |
| 2024-03-04 15:00:33 -0600 | Rating Details | |
| 2024-03-06 06:08:54 -0600 | Rating Details | |
| 2024-03-06 02:25:44 -0600 | Rating Details | |
| 2024-03-06 02:11:20 -0600 | Rating Details | |
| 2024-03-05 15:13:42 -0600 | Rating Details | |
| 2024-03-05 13:43:43 -0600 | Rating Details | |
| 2024-03-05 12:08:08 -0600 | Rating Details | |
| 2024-03-05 11:57:21 -0600 | Rating Details | |
| 2024-03-05 10:22:47 -0600 | Rating Details | |
| 2024-03-05 06:36:19 -0600 | Rating Details | |
| 2024-03-05 06:30:24 -0600 | Rating Details | |
| 2024-03-05 06:02:59 -0600 | Rating Details | |
| 2024-03-05 04:08:59 -0600 | Rating Details | |
| 2024-03-05 04:04:31 -0600 | Rating Details | |
| 2024-03-05 03:22:46 -0600 | Rating Details | |
| 2024-03-05 03:07:37 -0600 | Rating Details | |
| 2024-03-05 02:51:08 -0600 | Rating Details | |
| 2024-03-05 02:34:41 -0600 | Rating Details | |
| 2024-03-05 02:22:20 -0600 | Rating Details | |
| 2024-03-05 00:20:12 -0600 | Rating Details | |
| 2024-03-04 21:08:15 -0600 | Rating Details | |
| 2024-03-04 20:15:22 -0600 | Rating Details | |
| 2024-03-04 18:11:19 -0600 | Rating Details | |
| 2024-03-04 17:26:32 -0600 | Rating Details | |
| 2024-03-04 17:19:38 -0600 | Rating Details | |
| 2024-03-04 16:44:32 -0600 | Rating Details | |
| 2024-03-04 16:38:07 -0600 | Rating Details | |
| 2024-03-04 16:28:16 -0600 | Rating Details | |
| 2024-03-04 16:27:53 -0600 | Rating Details | |
| 2024-03-04 16:19:55 -0600 | Rating Details | |
| 2024-03-04 14:57:56 -0600 | Rating Details | |
| 2024-03-04 14:50:29 -0600 | Rating Details | |
| 2024-03-06 05:44:25 -0600 | Rating Details | |
| 2024-03-05 12:23:44 -0600 | Rating Details | |
| 2024-03-05 10:28:22 -0600 | Rating Details | |
| 2024-03-05 10:25:35 -0600 | Rating Details | |
| 2024-03-05 07:23:11 -0600 | Rating Details | |
| 2024-03-05 06:30:22 -0600 | Rating Details | |
| 2024-03-05 06:19:52 -0600 | Rating Details | |
| 2024-03-05 05:11:31 -0600 | Rating Details | |
| 2024-03-05 02:31:10 -0600 | Rating Details | |
| 2024-03-05 01:33:56 -0600 | Rating Details | |
| 2024-03-05 01:14:54 -0600 | Rating Details | |
| 2024-03-05 01:05:40 -0600 | Rating Details | |
| 2024-03-05 00:50:10 -0600 | Rating Details | |
| 2024-03-04 22:29:06 -0600 | Rating Details | |
| 2024-03-04 22:16:08 -0600 | Rating Details | |
| 2024-03-04 22:10:12 -0600 | Rating Details | |
| 2024-03-04 19:13:26 -0600 | Rating Details | |
| 2024-03-04 16:49:31 -0600 | Rating Details | |
| 2024-03-04 16:26:00 -0600 | Rating Details | |
| 2024-03-04 16:08:56 -0600 | Rating Details | |
| 2024-03-04 16:01:35 -0600 | Rating Details | |
| 2024-03-04 15:17:19 -0600 | Rating Details | |
| 2024-03-04 15:01:24 -0600 | Rating Details | |
| 2024-03-04 14:53:22 -0600 | Rating Details | |
| 2024-03-05 02:08:07 -0600 | Rating Details | |
| 2024-03-04 23:54:29 -0600 | Rating Details | |
| 2024-03-21 20:49:16 -0500 | Rating Details |